HIGHLIGHTS
- who: Chengdong Qin and colleagues from the University of Texas MD Anderson Cancer Center, United States have published the research: PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma, in the Journal: (JOURNAL)
- what: This investigation seeks to elucidate the role and mechanism of PIK3C2A in tumor progression. In this work, the relationships between PIK3C2A and tumor immunocyte infiltration were investigated by relying on the TIMER database.
- how: The scRNA-seq data were analyzed using R (version 4.0.3) with the Seurat package (version . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.